View in EDS HTML Full Text PDF Full Text

Efficacy of Roflumilast Foam, 0.3%, in Patients With Seborrheic Dermatitis: A Double-blind, Vehicle-Controlled Phase 2a Randomized Clinical Trial.

Saved in:
Bibliographic Details
Title: Efficacy of Roflumilast Foam, 0.3%, in Patients With Seborrheic Dermatitis: A Double-blind, Vehicle-Controlled Phase 2a Randomized Clinical Trial.
Authors: Zirwas MJ; Dermatologists of the Central States, Bexley, Ohio.; Probity Medical Research, Bexley, Ohio.; Ohio University, Bexley., Draelos ZD; Dermatology Consulting Services, High Point, North Carolina., DuBois J; DermResearch, Inc, Austin, Texas., Kircik LH; Icahn School of Medicine at Mount Sinai, New York, New York.; Physicians Skin Care, PLLC, Louisville, Kentucky.; Indiana Medical Center, Indianapolis.; Skin Sciences, PLLC, Louisville, Kentucky., Moore AY; Arlington Center for Dermatology, Arlington Research Center, Arlington, Texas.; Baylor University Medical Center, Dallas, Texas., Stein Gold L; Henry Ford Medical Center, Detroit, Michigan., Alonso-Llamazares J; Driven Research LLC, Coral Gables, Florida., Bukhalo M; Arlington Dermatology, Rolling Meadows, Illinois., Bruce S; SBA Dermatology, Houston, Texas., Eads K; The Indiana Clinical Trials Center, PC, Plainfield., Green LJ; George Washington University School of Medicine, Rockville, Maryland., Guenthner ST; The Dermatology Center of Indiana, PC, Plainfield.; The Indiana Clinical Trials Center, PC, Plainfield., Ferris LK; University of Pittsburgh, Department of Dermatology, Pittsburgh, Pennsylvania., Forman SB; ForCare Medical Center, Tampa, Florida., Kempers SE; Minnesota Clinical Study Center, Fridley., Lain E; Sanova Dermatology, Austin, Texas., Lynde CW; University of Toronto, Toronto, Ontario, Canada.; Lynde Centre for Dermatology, Markham, Ontario, Canada.; Probity Medical Research, Markham, Ontario, Canada., Pariser DM; Eastern Virginia Medical School, Norfolk.; Virginia Clinical Research, Inc, Norfolk., Toth DP; XLR8 Medical Research, Windsor, Ontario, Canada.; Probity Medical Research, Windsor, Ontario, Canada., Yamauchi PS; David Geffen School of Medicine at UCLA, Los Angeles, California.; Dermatology Institute & Skin Care Center, Inc, Santa Monica, California., Higham RC; Arcutis Biotherapeutics, Inc, Westlake Village, California., Krupa D; Arcutis Biotherapeutics, Inc, Westlake Village, California., Burnett P; Arcutis Biotherapeutics, Inc, Westlake Village, California., Berk DR; Arcutis Biotherapeutics, Inc, Westlake Village, California.
Source: JAMA dermatology [JAMA Dermatol] 2023 Jun 01; Vol. 159 (6), pp. 613-620.
Publication Type: Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101589530 Publication Model: Print Cited Medium: Internet ISSN: 2168-6084 (Electronic) Linking ISSN: 21686068 NLM ISO Abbreviation: JAMA Dermatol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37133856
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Efficacy of Roflumilast Foam, 0.3%, in Patients With Seborrheic Dermatitis: A Double-blind, Vehicle-Controlled Phase 2a Randomized Clinical Trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Zirwas+MJ%22">Zirwas MJ</searchLink>; Dermatologists of the Central States, Bexley, Ohio.; Probity Medical Research, Bexley, Ohio.; Ohio University, Bexley.<br /><searchLink fieldCode="AU" term="%22Draelos+ZD%22">Draelos ZD</searchLink>; Dermatology Consulting Services, High Point, North Carolina.<br /><searchLink fieldCode="AU" term="%22DuBois+J%22">DuBois J</searchLink>; DermResearch, Inc, Austin, Texas.<br /><searchLink fieldCode="AU" term="%22Kircik+LH%22">Kircik LH</searchLink>; Icahn School of Medicine at Mount Sinai, New York, New York.; Physicians Skin Care, PLLC, Louisville, Kentucky.; Indiana Medical Center, Indianapolis.; Skin Sciences, PLLC, Louisville, Kentucky.<br /><searchLink fieldCode="AU" term="%22Moore+AY%22">Moore AY</searchLink>; Arlington Center for Dermatology, Arlington Research Center, Arlington, Texas.; Baylor University Medical Center, Dallas, Texas.<br /><searchLink fieldCode="AU" term="%22Stein+Gold+L%22">Stein Gold L</searchLink>; Henry Ford Medical Center, Detroit, Michigan.<br /><searchLink fieldCode="AU" term="%22Alonso-Llamazares+J%22">Alonso-Llamazares J</searchLink>; Driven Research LLC, Coral Gables, Florida.<br /><searchLink fieldCode="AU" term="%22Bukhalo+M%22">Bukhalo M</searchLink>; Arlington Dermatology, Rolling Meadows, Illinois.<br /><searchLink fieldCode="AU" term="%22Bruce+S%22">Bruce S</searchLink>; SBA Dermatology, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Eads+K%22">Eads K</searchLink>; The Indiana Clinical Trials Center, PC, Plainfield.<br /><searchLink fieldCode="AU" term="%22Green+LJ%22">Green LJ</searchLink>; George Washington University School of Medicine, Rockville, Maryland.<br /><searchLink fieldCode="AU" term="%22Guenthner+ST%22">Guenthner ST</searchLink>; The Dermatology Center of Indiana, PC, Plainfield.; The Indiana Clinical Trials Center, PC, Plainfield.<br /><searchLink fieldCode="AU" term="%22Ferris+LK%22">Ferris LK</searchLink>; University of Pittsburgh, Department of Dermatology, Pittsburgh, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Forman+SB%22">Forman SB</searchLink>; ForCare Medical Center, Tampa, Florida.<br /><searchLink fieldCode="AU" term="%22Kempers+SE%22">Kempers SE</searchLink>; Minnesota Clinical Study Center, Fridley.<br /><searchLink fieldCode="AU" term="%22Lain+E%22">Lain E</searchLink>; Sanova Dermatology, Austin, Texas.<br /><searchLink fieldCode="AU" term="%22Lynde+CW%22">Lynde CW</searchLink>; University of Toronto, Toronto, Ontario, Canada.; Lynde Centre for Dermatology, Markham, Ontario, Canada.; Probity Medical Research, Markham, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Pariser+DM%22">Pariser DM</searchLink>; Eastern Virginia Medical School, Norfolk.; Virginia Clinical Research, Inc, Norfolk.<br /><searchLink fieldCode="AU" term="%22Toth+DP%22">Toth DP</searchLink>; XLR8 Medical Research, Windsor, Ontario, Canada.; Probity Medical Research, Windsor, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Yamauchi+PS%22">Yamauchi PS</searchLink>; David Geffen School of Medicine at UCLA, Los Angeles, California.; Dermatology Institute & Skin Care Center, Inc, Santa Monica, California.<br /><searchLink fieldCode="AU" term="%22Higham+RC%22">Higham RC</searchLink>; Arcutis Biotherapeutics, Inc, Westlake Village, California.<br /><searchLink fieldCode="AU" term="%22Krupa+D%22">Krupa D</searchLink>; Arcutis Biotherapeutics, Inc, Westlake Village, California.<br /><searchLink fieldCode="AU" term="%22Burnett+P%22">Burnett P</searchLink>; Arcutis Biotherapeutics, Inc, Westlake Village, California.<br /><searchLink fieldCode="AU" term="%22Berk+DR%22">Berk DR</searchLink>; Arcutis Biotherapeutics, Inc, Westlake Village, California.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101589530%22">JAMA dermatology</searchLink> [JAMA Dermatol] 2023 Jun 01; Vol. 159 (6), pp. 613-620.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Medical+Association%22">American Medical Association </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101589530 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2168-6084 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221686068%22">21686068 </searchLink><i>NLM ISO Abbreviation: </i>JAMA Dermatol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37133856
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1001/jamadermatol.2023.0846
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 613
    Titles:
      – TitleFull: Efficacy of Roflumilast Foam, 0.3%, in Patients With Seborrheic Dermatitis: A Double-blind, Vehicle-Controlled Phase 2a Randomized Clinical Trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Zirwas MJ
      – PersonEntity:
          Name:
            NameFull: Draelos ZD
      – PersonEntity:
          Name:
            NameFull: DuBois J
      – PersonEntity:
          Name:
            NameFull: Kircik LH
      – PersonEntity:
          Name:
            NameFull: Moore AY
      – PersonEntity:
          Name:
            NameFull: Stein Gold L
      – PersonEntity:
          Name:
            NameFull: Alonso-Llamazares J
      – PersonEntity:
          Name:
            NameFull: Bukhalo M
      – PersonEntity:
          Name:
            NameFull: Bruce S
      – PersonEntity:
          Name:
            NameFull: Eads K
      – PersonEntity:
          Name:
            NameFull: Green LJ
      – PersonEntity:
          Name:
            NameFull: Guenthner ST
      – PersonEntity:
          Name:
            NameFull: Ferris LK
      – PersonEntity:
          Name:
            NameFull: Forman SB
      – PersonEntity:
          Name:
            NameFull: Kempers SE
      – PersonEntity:
          Name:
            NameFull: Lain E
      – PersonEntity:
          Name:
            NameFull: Lynde CW
      – PersonEntity:
          Name:
            NameFull: Pariser DM
      – PersonEntity:
          Name:
            NameFull: Toth DP
      – PersonEntity:
          Name:
            NameFull: Yamauchi PS
      – PersonEntity:
          Name:
            NameFull: Higham RC
      – PersonEntity:
          Name:
            NameFull: Krupa D
      – PersonEntity:
          Name:
            NameFull: Burnett P
      – PersonEntity:
          Name:
            NameFull: Berk DR
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2023 Jun 01
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 2168-6084
          Numbering:
            – Type: volume
              Value: 159
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: JAMA dermatology
              Type: main
ResultId 1